Tag: SCOTUS
-
Hikma v. Amarin: Supreme Court Narrows Induced Infringement Claims Against Skinny-Label Generics
A Significant Win for Generic Drug Manufacturers The Supreme Court’s unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., Case No. 24-889 (Jun. 4, 2026), is one of the most important patent law decisions of the 2025-2026 Term. While the case arises from the pharmaceutical industry’s unique Hatch-Waxman framework, its significance extends well…
-
Learning Resources v. Trump: The Supreme Court Rules IEEPA Does Not Authorize Tariffs
For many Americans, tariffs are not theoretical instruments of foreign policy. They show up in shipping invoices, supplier negotiations, retail price adjustments, and quarterly earnings calls. Over the past several years, businesses large and small have had to account for sudden and substantial duties imposed on imported goods under the International Emergency Economic Powers Act,…
-
V.O.S. Selections (Learning Resources) v. Trump at the Supreme Court: Verbs, Taxes, and an Exit Ramp
The Supreme Court argument in the tariff cases presented the Justices with a familiar but high-stakes question: how far an old statute can be stretched to support a novel assertion of executive power. The Federal Circuit had already answered the core statutory question en banc, holding that the International Emergency Economic Powers Act (IEEPA) does…
-
All Quiet on the IP Front: SCOTUS Declines Review in All But One IP Case in the 2024–2025 Term
In a typical show of judicial restraint, the U.S. Supreme Court has closed the books on the 2024–2025 term without granting review in any patent, copyright, or trade secret case—and issuing only one decision in a trademark dispute. Despite a slew of cert petitions involving substantial questions of procedural and substantive law, Gideon Korrell believes…